speb/financial-data huggingface dataset:
MEDI.OL balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 15145000.00
MEDI.OL income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 141251000.00
MEDI.OL income_statement (annual, 2022-12-31) — Total Other Finance Cost: -1199000.00
MEDI.OL balance_sheet (annual, 2022-12-31) — Total Tax Payable: 33041000.00
MEDI.OL balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 85046.00
MEDI.OL balance_sheet (annual, 2022-12-31) — Treasury Stock: 21000.00
MEDI.OL balance_sheet (annual, 2022-12-31) — Work In Process: 2467000.00
MEDI.OL balance_sheet (annual, 2022-12-31) — Working Capital: 286072000.00
MEDI.OL income_statement (annual, 2023-12-31) — +Operating Expense: 277402000.00
MEDI.OL income_statement (annual, 2023-12-31) — +Total Revenue: 521109000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Accounts Payable: 25083000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Accounts Receivable: 74303000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -133329000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 66595000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -997000.00
MEDI.OL income_statement (annual, 2023-12-31) — Amortization: 4021000.00
MEDI.OL income_statement (annual, 2023-12-31) — Basic Average Shares: 18267157.00
MEDI.OL income_statement (annual, 2023-12-31) — Basic EPS: 5.68
MEDI.OL cash_flow (annual, 2023-12-31) — Beginning Cash Position: 152641000.00
MEDI.OL cash_flow (annual, 2023-12-31) — Capital Expenditure: -29726000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 17644000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Capital Stock: 4585000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 146082000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 146082000.00
MEDI.OL cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -82180000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Cash Financial: 146082000.00
MEDI.OL cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -16891000.00
MEDI.OL cash_flow (annual, 2023-12-31) — Change In Inventory: -31058000.00
MEDI.OL cash_flow (annual, 2023-12-31) — Change In Payable: 613000.00
MEDI.OL cash_flow (annual, 2023-12-31) — Change In Receivables: 27354000.00
MEDI.OL cash_flow (annual, 2023-12-31) — Change In Working Capital: -19982000.00
MEDI.OL cash_flow (annual, 2023-12-31) — Changes In Cash: -1420000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Common Stock: 4585000.00
MEDI.OL cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -82180000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Common Stock Equity: 397941000.00
MEDI.OL income_statement (annual, 2023-12-31) — Cost Of Revenue: 112280000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Current Assets: 391566000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 8384000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 8384000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Current Liabilities: 94284000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Current Provisions: 988000.00
MEDI.OL cash_flow (annual, 2023-12-31) — Depreciation: 23657000.00
MEDI.OL cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 23657000.00
MEDI.OL income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 23670000.00
MEDI.OL income_statement (annual, 2023-12-31) — Depreciation Income Statement: 19649000.00
MEDI.OL income_statement (annual, 2023-12-31) — Diluted Average Shares: 18296157.00
MEDI.OL income_statement (annual, 2023-12-31) — Diluted EPS: 5.67
MEDI.OL income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 103823000.00
MEDI.OL income_statement (annual, 2023-12-31) — EBIT: 135785000.00
MEDI.OL income_statement (annual, 2023-12-31) — EBITDA: 159455000.00
MEDI.OL cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 2651000.00
MEDI.OL cash_flow (annual, 2023-12-31) — End Cash Position: 153872000.00
MEDI.OL cash_flow (annual, 2023-12-31) — Financing Cash Flow: -90892000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Finished Goods: 64047000.00
MEDI.OL cash_flow (annual, 2023-12-31) — Free Cash Flow: 89472000.00
MEDI.OL income_statement (annual, 2023-12-31) — General And Administrative Expense: 42167000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Goodwill: 14128000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 45374000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 75300000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Gross PPE: 190635000.00
MEDI.OL income_statement (annual, 2023-12-31) — Gross Profit: 408829000.00
MEDI.OL income_statement (annual, 2023-12-31) — Interest Expense: 573000.00
MEDI.OL income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 573000.00
MEDI.OL income_statement (annual, 2023-12-31) — Interest Income: 3275000.00
MEDI.OL income_statement (annual, 2023-12-31) — Interest Income Non Operating: 3275000.00
MEDI.OL cash_flow (annual, 2023-12-31) — Interest Received Cfo: 6009000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Inventories Adjustments Allowances: -8217000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Inventory: 145391000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Invested Capital: 397941000.00
MEDI.OL cash_flow (annual, 2023-12-31) — Investing Cash Flow: -29726000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 9260000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 9260000.00
MEDI.OL income_statement (annual, 2023-12-31) — Net Income: 103823000.00
MEDI.OL income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 103823000.00
MEDI.OL income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 103823000.00
MEDI.OL income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 103823000.00
MEDI.OL income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 103823000.00
MEDI.OL cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 135212000.00
MEDI.OL income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 103823000.00
MEDI.OL cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -13327000.00
MEDI.OL income_statement (annual, 2023-12-31) — Net Interest Income: 2839000.00
MEDI.OL income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 2839000.00
MEDI.OL cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 6009000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Net PPE: 57306000.00
MEDI.OL cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -16399000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 352567000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 4234000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 5142000.00
MEDI.OL income_statement (annual, 2023-12-31) — Normalized EBITDA: 159455000.00
MEDI.OL income_statement (annual, 2023-12-31) — Normalized Income: 103823000.00
MEDI.OL cash_flow (annual, 2023-12-31) — Operating Cash Flow: 119198000.00
MEDI.OL income_statement (annual, 2023-12-31) — Operating Income: 131427000.00
MEDI.OL income_statement (annual, 2023-12-31) — Operating Revenue: 521109000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 18281719.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 1413000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 31246000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Other Inventories: 11284000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Other Non Current Assets: -1000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: -1000.00
MEDI.OL income_statement (annual, 2023-12-31) — Other Operating Expenses: 63291000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Other Properties: 190635000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Other Receivables: 6371000.00
MEDI.OL income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Payables: 64875000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 9882000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Prepaid Assets: 4671000.00
MEDI.OL income_statement (annual, 2023-12-31) — Pretax Income: 135212000.00
MEDI.OL cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -13327000.00
MEDI.OL cash_flow (annual, 2023-12-31) — Purchase Of PPE: -16399000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Raw Materials: 74673000.00
MEDI.OL income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 112280000.00
MEDI.OL income_statement (annual, 2023-12-31) — Reconciled Depreciation: 23657000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Restricted Cash: 7790000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Retained Earnings: 307380000.00
MEDI.OL income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 9717000.00
MEDI.OL income_statement (annual, 2023-12-31) — Selling General And Administration: 51884000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Share Issued: 18337336.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Stockholders Equity: 397941000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Tangible Book Value: 352567000.00
MEDI.OL income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
MEDI.OL income_statement (annual, 2023-12-31) — Tax Provision: 31389000.00
MEDI.OL income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.23
MEDI.OL balance_sheet (annual, 2023-12-31) — Taxes Receivable: 6958000.00
MEDI.OL cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -25699000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Total Assets: 505718000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Total Capitalization: 397941000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Total Debt: 17644000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 397941000.00
MEDI.OL income_statement (annual, 2023-12-31) — Total Expenses: 389682000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 107777000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 114152000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 13493000.00
MEDI.OL income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 131442000.00
MEDI.OL income_statement (annual, 2023-12-31) — Total Other Finance Cost: -137000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Total Tax Payable: 39792000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 55617.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Treasury Stock: 13000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Work In Process: 3604000.00
MEDI.OL balance_sheet (annual, 2023-12-31) — Working Capital: 297282000.00
MEDI.OL balance_sheet (quarterly, 2024-09-30) — Cash Financial: 127324000.00
MEDI.OL income_statement (quarterly, 2024-09-30) — Interest Expense: 0.00
MEDI.OL income_statement (quarterly, 2024-09-30) — Interest Expense Non Operating: 0.00
MEDI.OL cash_flow (quarterly, 2024-09-30) — Other Cash Adjustment Outside Changein Cash: 0.00
MEDI.OL balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: -597000.00
MEDI.OL income_statement (quarterly, 2024-09-30) — Total Unusual Items: -1780000.00
MEDI.OL income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: -1780000.00
MEDI.OL income_statement (annual, 2024-12-31) — +Operating Expense: 317844000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — +Operating Expense: 91709000.00
MEDI.OL income_statement (annual, 2024-12-31) — +Total Revenue: 562599000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — +Total Revenue: 151139000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Accounts Payable: 17730000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 17730000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Accounts Receivable: 68980000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 68980000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -153979000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -153979000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 67656000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 67656000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -997000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -997000.00
MEDI.OL income_statement (annual, 2024-12-31) — Amortization: 3284000.00
MEDI.OL income_statement (annual, 2024-12-31) — Basic Average Shares: 18314219.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Basic Average Shares: 18314219.00
MEDI.OL income_statement (annual, 2024-12-31) — Basic EPS: 5.67
MEDI.OL income_statement (quarterly, 2024-12-31) — Basic EPS: 1.16
MEDI.OL cash_flow (annual, 2024-12-31) — Beginning Cash Position: 153872000.00
MEDI.OL cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 127323000.00
MEDI.OL cash_flow (annual, 2024-12-31) — Capital Expenditure: -24693000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 34364000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 34364000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Capital Stock: 4584000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Capital Stock: 4584000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 171272000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 171272000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 171272000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 171272000.00
MEDI.OL cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -82414000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Cash Financial: 171272000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Cash Financial: 171272000.00
MEDI.OL cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 28655000.00
MEDI.OL cash_flow (annual, 2024-12-31) — Change In Inventory: -15130000.00
MEDI.OL cash_flow (annual, 2024-12-31) — Change In Payable: 1951000.00
MEDI.OL cash_flow (annual, 2024-12-31) — Change In Receivables: 5323000.00
MEDI.OL cash_flow (annual, 2024-12-31) — Change In Working Capital: 20799000.00
MEDI.OL cash_flow (quarterly, 2024-12-31) — Change In Working Capital: 3166000.00
MEDI.OL cash_flow (annual, 2024-12-31) — Changes In Cash: 26882000.00
MEDI.OL cash_flow (quarterly, 2024-12-31) — Changes In Cash: 51887000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Common Stock: 4584000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Common Stock: 4584000.00
MEDI.OL cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -82414000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Common Stock Equity: 436610000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 436610000.00
MEDI.OL cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
MEDI.OL cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
MEDI.OL income_statement (annual, 2024-12-31) — Cost Of Revenue: 113680000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 33586000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Current Assets: 429131000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Current Assets: 429131000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 9305000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 9305000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 9305000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 9305000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Current Liabilities: 107367000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 107367000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Current Provisions: 2831000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Current Provisions: 2831000.00
MEDI.OL cash_flow (annual, 2024-12-31) — Depreciation: 15395000.00
MEDI.OL cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 15395000.00
MEDI.OL income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 24510000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 6542000.00
MEDI.OL income_statement (annual, 2024-12-31) — Depreciation Income Statement: 24510000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 6542000.00
MEDI.OL income_statement (annual, 2024-12-31) — Diluted Average Shares: 18314219.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 18314219.00
MEDI.OL income_statement (annual, 2024-12-31) — Diluted EPS: 5.67
MEDI.OL income_statement (quarterly, 2024-12-31) — Diluted EPS: 1.16
MEDI.OL income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 103832000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 21302000.00
MEDI.OL income_statement (annual, 2024-12-31) — EBIT: 134705000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — EBIT: 25844000.00
MEDI.OL income_statement (annual, 2024-12-31) — EBITDA: 159215000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — EBITDA: 32386000.00
MEDI.OL cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -1544000.00
MEDI.OL cash_flow (annual, 2024-12-31) — End Cash Position: 179210000.00
MEDI.OL cash_flow (quarterly, 2024-12-31) — End Cash Position: 179210000.00
MEDI.OL cash_flow (annual, 2024-12-31) — Financing Cash Flow: -91529000.00
MEDI.OL cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: -2828000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Finished Goods: 71023000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Finished Goods: 71023000.00
MEDI.OL cash_flow (annual, 2024-12-31) — Free Cash Flow: 118411000.00
MEDI.OL cash_flow (quarterly, 2024-12-31) — Free Cash Flow: 63915000.00
MEDI.OL income_statement (annual, 2024-12-31) — General And Administrative Expense: 46314000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Goodwill: 14128000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Goodwill: 14128000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 60717000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 60717000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 69977000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 69977000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Gross PPE: 225760000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Gross PPE: 225760000.00
MEDI.OL income_statement (annual, 2024-12-31) — Gross Profit: 448919000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Gross Profit: 117553000.00
MEDI.OL income_statement (annual, 2024-12-31) — Interest Expense: 459000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Interest Expense: 467000.00
MEDI.OL income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 459000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 467000.00
MEDI.OL income_statement (annual, 2024-12-31) — Interest Income: 4569000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Interest Income: 2637000.00
MEDI.OL income_statement (annual, 2024-12-31) — Interest Income Non Operating: 4569000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 2637000.00
MEDI.OL cash_flow (annual, 2024-12-31) — Interest Received Cfo: 1068000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Inventories Adjustments Allowances: -9007000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Inventories Adjustments Allowances: -9007000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Inventory: 160521000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Inventory: 160521000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Invested Capital: 436610000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Invested Capital: 436610000.00
MEDI.OL cash_flow (annual, 2024-12-31) — Investing Cash Flow: -24693000.00
MEDI.OL cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -9200000.00
MEDI.OL cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 25059000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 25059000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 25059000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 25059000.00
MEDI.OL cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
MEDI.OL cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
MEDI.OL income_statement (annual, 2024-12-31) — Net Income: 103832000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Net Income: 21302000.00
MEDI.OL income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 103832000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 21302000.00
MEDI.OL income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 103832000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 21302000.00
MEDI.OL income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 103832000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 21302000.00
MEDI.OL income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 103832000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 21302000.00
MEDI.OL cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 134246000.00
MEDI.OL cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: 28300000.00
MEDI.OL income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 103832000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 21302000.00
MEDI.OL cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -18625000.00
MEDI.OL income_statement (annual, 2024-12-31) — Net Interest Income: 4801000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Net Interest Income: 2859000.00
MEDI.OL income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 4801000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: 2859000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Net PPE: 71781000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Net PPE: 71781000.00
MEDI.OL cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -6068000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 375893000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 375893000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 5931000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Revenue: 5931000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 9022000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Assets: 9022000.00
MEDI.OL income_statement (annual, 2024-12-31) — Normalized EBITDA: 159215000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 30606000.00
MEDI.OL income_statement (annual, 2024-12-31) — Normalized Income: 103832000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Normalized Income: 19962156.89
MEDI.OL cash_flow (annual, 2024-12-31) — Operating Cash Flow: 143104000.00
MEDI.OL cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: 63915000.00
MEDI.OL income_statement (annual, 2024-12-31) — Operating Income: 131075000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Operating Income: 25844000.00
MEDI.OL income_statement (annual, 2024-12-31) — Operating Revenue: 562599000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Operating Revenue: 151139000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 18314219.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 18314219.00
MEDI.OL cash_flow (annual, 2024-12-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
MEDI.OL cash_flow (quarterly, 2024-12-31) — Other Cash Adjustment Outside Changein Cash: 0.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Other Current Assets: -1000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Other Current Assets: -1000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 10427000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 10427000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Other Equity Interest: 387855000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Other Equity Interest: 387855000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 46589000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 46589000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Other Inventories: 11221000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Other Inventories: 11221000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 1561000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 1561000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 1000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 1000.00
MEDI.OL income_statement (annual, 2024-12-31) — Other Operating Expenses: 68301000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 32423000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Other Properties: 225760000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Other Properties: 225760000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Other Receivables: 9063000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Other Receivables: 9063000.00
MEDI.OL income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Payables: 56992000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Payables: 56992000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 9976000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 9976000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Prepaid Assets: 5635000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 5635000.00
MEDI.OL income_statement (annual, 2024-12-31) — Pretax Income: 134246000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Pretax Income: 28300000.00
MEDI.OL cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -18625000.00
MEDI.OL cash_flow (annual, 2024-12-31) — Purchase Of PPE: -6068000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Raw Materials: 85025000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Raw Materials: 85025000.00
MEDI.OL income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 113680000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 33586000.00
MEDI.OL income_statement (annual, 2024-12-31) — Reconciled Depreciation: 15395000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 6542000.00
MEDI.OL cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Restricted Cash: 7938000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 7938000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Retained Earnings: 328798000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 328798000.00
MEDI.OL income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 14244000.00
MEDI.OL income_statement (annual, 2024-12-31) — Selling General And Administration: 60558000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Share Issued: 18337336.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Share Issued: 18337336.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Stockholders Equity: 436610000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 436610000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Tangible Book Value: 375893000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 375893000.00
MEDI.OL income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 440156.89
MEDI.OL income_statement (annual, 2024-12-31) — Tax Provision: 30414000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Tax Provision: 6998000.00
MEDI.OL income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.23
MEDI.OL income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.25
MEDI.OL balance_sheet (annual, 2024-12-31) — Taxes Receivable: 5723000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 5723000.00
MEDI.OL cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -28404000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Total Assets: 574968000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Total Assets: 574968000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Total Capitalization: 436610000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 436610000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Total Debt: 34364000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Total Debt: 34364000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 436610000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 436610000.00
MEDI.OL income_statement (annual, 2024-12-31) — Total Expenses: 431524000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Total Expenses: 125295000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 138358000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 138358000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 145837000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 145837000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 30991000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 30991000.00
MEDI.OL income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 131076000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: 25844000.00
MEDI.OL income_statement (annual, 2024-12-31) — Total Other Finance Cost: -691000.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Total Other Finance Cost: -222000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Total Tax Payable: 39262000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 39262000.00
MEDI.OL income_statement (annual, 2024-12-31) — Total Unusual Items: 0.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Total Unusual Items: 1780000.00
MEDI.OL income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
MEDI.OL income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 1780000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 23117.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 23117.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Treasury Stock: 6000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 6000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Work In Process: 2259000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Work In Process: 2259000.00
MEDI.OL balance_sheet (annual, 2024-12-31) — Working Capital: 321764000.00
MEDI.OL balance_sheet (quarterly, 2024-12-31) — Working Capital: 321764000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — +Operating Expense: 91811000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — +Total Revenue: 181547000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 92295000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 44172000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Basic Average Shares: 18299000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Basic EPS: 2.37
MEDI.OL cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 179210000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 26172000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Capital Stock: 4585000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 183448000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 183448000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Cash Financial: 183448000.00
MEDI.OL cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -19917000.00
MEDI.OL cash_flow (quarterly, 2025-03-31) — Changes In Cash: 4237000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Common Stock: 4585000.00
MEDI.OL cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: 0.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 466422000.00
MEDI.OL cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -7919000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 30565000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Current Assets: 470202000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 120192000.00
MEDI.OL cash_flow (quarterly, 2025-03-31) — Depreciation: 3375000.00
MEDI.OL cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 3375000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 5572000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 5572000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 18299000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Diluted EPS: 2.37
MEDI.OL income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 43425000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — EBIT: 60140000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — EBITDA: 65712000.00
MEDI.OL cash_flow (quarterly, 2025-03-31) — End Cash Position: 183447000.00
MEDI.OL cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -10116000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Finished Goods: 70051000.00
MEDI.OL cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 18821000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Goodwill: 14128000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 75251000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Gross Profit: 150982000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Interest Expense: 3430000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 3430000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Interest Income: 1426000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 1426000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Inventories Adjustments Allowances: -10432000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Inventory: 167876000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Invested Capital: 466422000.00
MEDI.OL cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -4468000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 26172000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 26172000.00
MEDI.OL cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -7919000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Net Income: 43425000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 43425000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 43425000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 43425000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 43425000.00
MEDI.OL cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 56710000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 43425000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Net Interest Income: -1992000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -1992000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Net PPE: 71864000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 391171000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 4532000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 65712000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Normalized Income: 43425000.00
MEDI.OL cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 18821000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Operating Income: 59171000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Operating Revenue: 181547000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 18271676.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 417665000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 61123000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Other Inventories: 16801000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 27642000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Other Receivables: 26583000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Pretax Income: 56710000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Raw Materials: 90591000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 30565000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 3375000.00
MEDI.OL cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -7919000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Share Issued: 18337336.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 466422000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 391171000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Tax Provision: 13285000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.23
MEDI.OL cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: -15531000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Total Assets: 617318000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 466422000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Total Debt: 26172000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 466422000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Total Expenses: 122376000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 150896000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 147116000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 30704000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 59172000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: -12000.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
MEDI.OL income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 65660.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Work In Process: 865000.00
MEDI.OL balance_sheet (quarterly, 2025-03-31) — Working Capital: 350010000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — +Operating Expense: 84302000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — +Total Revenue: 169076000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 94121000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 44172000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Basic Average Shares: 18253000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Basic EPS: 2.35
MEDI.OL cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 183447000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 22033000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Capital Stock: 4585000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 96351000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 96351000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Cash Financial: 96351000.00
MEDI.OL cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -9647000.00
MEDI.OL cash_flow (quarterly, 2025-06-30) — Changes In Cash: -87096000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Common Stock: 4585000.00
MEDI.OL cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -109885000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 383806000.00
MEDI.OL cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -4653000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 30638000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Current Assets: 388072000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 123745000.00
MEDI.OL cash_flow (quarterly, 2025-06-30) — Depreciation: 8555000.00
MEDI.OL cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 8555000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 6358000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 6358000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 18253000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Diluted EPS: 2.35
MEDI.OL income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 42984000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — EBIT: 56347000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — EBITDA: 64902000.00
MEDI.OL cash_flow (quarterly, 2025-06-30) — End Cash Position: 96351000.00
MEDI.OL cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -116737000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Finished Goods: 81691000.00
MEDI.OL cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 37653000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Goodwill: 14128000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 76581000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Gross Profit: 138438000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Interest Expense: 0.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 0.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Interest Income: 1581000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 1581000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Inventories Adjustments Allowances: -10432000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Inventory: 174341000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Invested Capital: 383806000.00
MEDI.OL cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -8012000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 22033000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 22033000.00
MEDI.OL cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -4653000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Net Income: 42984000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 42984000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 42984000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 42984000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 42984000.00
MEDI.OL cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 56347000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 42984000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Net Interest Income: 685000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 685000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Net PPE: 70384000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 307225000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 5453000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 64902000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Normalized Income: 42984000.00
MEDI.OL cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 37653000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Operating Income: 54136000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Operating Revenue: 169076000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 18273093.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 1000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 335049000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 62453000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Other Inventories: 12523000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 1000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 30030000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Other Receivables: 23258000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Pretax Income: 56347000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Raw Materials: 90184000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 30638000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 8555000.00
MEDI.OL cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -4653000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Share Issued: 18337336.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 383806000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 307225000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Tax Provision: 13363000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.24
MEDI.OL cash_flow (quarterly, 2025-06-30) — Taxes Refund Paid: -12809000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Total Assets: 535037000.00